The global 3D printing photopolymers industry size is anticipated to reach US$ 935.0 million in 2023. Between 2023 and 2033, the market is forecast to increase at a CAGR of 18.3%, and by the end of 2033, it is anticipated to reach US$ 5.0 billion. 3D printing, also known as additive manufacturing, has emerged as …
Category Archives: Healthcare Trends
Global USA Electronic Health Records (EHR) Industry is anticipated to soar to US$ 15.3 Billion by 2033 in the US Healthcare Sector, according to FMI’s analysis
The USA electronic health records (EHR) industry size is anticipated to reach a value of US$ 9.1 billion in 2023 and grow at a CAGR of 5.3% to reach US$ 15.3 billion by 2033. In 2022, the USA market will be led by EHR Software in the solution sector, with a market share of roughly …
Global VR Stroke Rehabilitation Industry is on an upward trajectory, anticipated to attain a value of US$ 376.0 billion by 2033, influenced by the increasing prevalence of strokes | FMI
The global VR stroke rehabilitation industry size is expected to reach US$ 376.0 billion by 2033, growing at a CAGR of 9.2% over the forecast period, according to a recent report by Future Market Insights. The growth of the VR stroke rehabilitation market is attributed to a number of factors, including the rising prevalence of …
Global Nephroblastoma Treatment Industry is projected to be US$ 5.44 Billion by 2033 | FMI
According to Future Market Insights, the global nephroblastoma therapeutics industry size is projected to rise at a steady growth valued at US$ 2.12 billion in 2023, with a 9.88% CAGR until 2033, being valued at US$ 5.44 billion. The important factors that are compelling the growth of the revenue of the nephroblastoma therapeutics market are …
Global Nerve Entrapment Syndrome Therapeutics Industry is expected to grow at a 6.81% CAGR and reach US$ 8.04 Billion by 2033 as per FMI’s study
According to Future Market Insights, the global nerve entrapment syndrome therapeutics industry size is projected to rise at a steady growth valued at US$ 4.16 billion in 2023, with a 6.81% CAGR until 2033, being valued at US$ 8.04 billion. As per FMI, around 60–70% of people suffering from diabetes are projected to have diabetic …
Global Nasopharyngeal Carcinoma Treatment Industry will achieve a US$ 2.1 Billion valuation by 2033, primarily driven by Advanced Healthcare Solutions, FMI
During the forecast period 2023 to 2033, the global nasopharyngeal carcinoma treatment industry size is expected to grow at a value of 5.9% CAGR, according to Future Market Insights. The industry is valued at US$ 1.18 Billion in 2023. By the year 2033, the global market for Nasopharyngeal carcinoma treatment is expected to rise up …
Global Non-Sterile Liquids/Suspensions Industry is forecasted to experience a 6.5% CAGR expansion by 2033, with Personalized Medicine identified as the primary driver, per FMI
The global non-sterile liquids/suspensions industry size is anticipated to reach US$ 2.8 billion in 2023 and US$ 5.2 billion by the end of 2033. Between 2023 and 2033, the market is anticipated to develop at a 6.5% CAGR. According to a recent analysis by Future Market Insights, the oral dosage form would dominate the global …
Global Post-Operative Cataract Surgery Inflammation Treatment Industry is expected to achieve US$ 8.78 Billion by 2033, growing at a 6.77% CAGR, according to FMI
According to Future Market Insights, the global post-operative cataract surgery inflammation treatment industry growth is projected to rise at a steady growth valued at US$ 4.56 billion 2023 with a 6.77% CAGR until 2033, being valued at US$ 8.78 billion. The rising number of cortical necrosis therapeutics are being delivered through retail pharmacies and the …
Global Respiratory Distress Syndrome Management Industry achieving US$ 177.7 Billion by 2033, propelled by solutions aimed at managing breathlessness | FMI
The global respiratory distress syndrome management industry size is slated to reach a valuation of US$ 115.4 billion in 2023. According to Future Market Insights, The Respiratory Distress Syndrome Management Market is anticipated to increase steadily from its current value of US$ 115.4 billion to US$ 177.7 billion by 2033, at a CAGR of 4.41%. Also, according to …
Global Cerebral Vein Thrombosis Treatment Industry is poised for a steady growth rate of 12.3% CAGR from 2023 to 2033
During the forecast period 2023 to 2033, the global cerebral vein thrombosis treatment industry garnered a market value of US$ 191.53 million in 2023 is expected to grow at a value of 12.3% CAGR, according to Future Market Insights. By the year 2033, the global market for Cerebral vein thrombosis treatment is expected to rise …